In a preclinical model of hepatocellular carcinoma (HCC), estrogen receptor signaling increased cancer cell death through NLRP3 inflammasome-initiated, caspase-1-dependent pyroptosis and inhibition of autophagy in cancer cells [177]. Here, NLRP3 is linked to hepatocellular carcinoma.